Shockwave Medical (SWAV) Reports In-Line Q3 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. BROS
3. ARM
4. FIS
5. EXPE
6. QCOM
7. DDOG
8. PAYC
9. CHYM
10. CPAY

Go back to Shockwave Medical (SWAV) Reports In-Line Q3 EPS

Shockwave Medical Reports Third Quarter 2021 Financial Results

November 8, 2021 4:05 PM EST

SANTA CLARA, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended September 30, 2021.

Recent Highlights

Recognized revenue of $65.2 million for the third quarter of 2021, representing an increase of 233% from the same period in 2020DISRUPT PAD III observational study results of peripheral IVL featured as a late breaking presentation at the VIVA21 conferenceFirst one-year results, a... More